From the Book - 35th edition.
Individual drug monographs
Appendixes : A. Selected new drugs: atoltivimab/maftivimab/odesivimab-ebgn ; amisulpride ; avapritinib ; belantamub mafodotin-blmf ; bempedoic acid/ezetimibe ; capmatinib ; collagenase clostridium histolyticum-aaes ; daratumumab/hyaluronidase-fihj ; decitabine/cedazuridine ; eptinezumab-jjmr ; fenfluramine ; fostemsavir ; lumasiran ; lurbinectedin ; Moderna COVID-19 vaccine ; naxitamab-gqgk ; nifurtimox ; oliceridine ; opicapone ; peanut (Arachis hypogaea) allergen powder-dnfp ; pemigatinib ; pertuzumab/trastuzumab/hyaluronidase-zzxf ; Pfizer-BioNTech COVID-19 vaccine ; pralsetinib ; remdesivir ; remimazolam ; rimegepant ; ripretinib ; risdiplam ; sacituzumab govitecan-hziy ; selumetinib ; somapacitin-beco ; tazemetostat ; teprotumumab-trbw ; tucatinib ; vibegron ; viltolarsen
B. Ophthalmic, nasal, topical, and otic products
D. Recent FDA drug approvals.
